Evidence map›Paper›PMID 28545493›Full record

Trial reportBMC health services research2017

Three approaches to glucose monitoring in non-insulin treated diabetes: a pragmatic randomized clinical trial protocol.

Laura A Young, John B Buse, Mark A Weaver, Maihan B Vu, April Reese, C Madeline Mitchell, Tamara Blakeney, Kimberlea Grimm, Jennifer Rees, Katrina E Donahue

Registry-linked trialOpen access · goldAbstract readPragmatic Clinical TrialRandomized Controlled Trial
In one paragraph

Trial report in BMC health services research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02033499 (Effect of Glucose Monitoring on Patient and Provider Outcomes in Non-insulin Treated Diabetes), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02033499 nacompletednot on this map

Effect of Glucose Monitoring on Patient and Provider Outcomes in Non-insulin Treated Diabetes

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2014 to 2016Enrolled450ConditionsDIABETES MELLITUS, NONINSULIN-DEPENDENT, 2 (Disorder)ArmsSMBG
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Laura A YoungDivision of Endocrinology, Department of General Internal Medicine, School of Medicine, University of North Carolina at Chapel Hill, 8025 Burnett Womack Building, Campus Box # 7172 UNC-CH, Chapel Hill, NC, 27599-7170, USA. laura_young@med.unc.edu.
John B BuseDivision of Endocrinology, Department of General Internal Medicine, School of Medicine, University of North Carolina at Chapel Hill, 8025 Burnett Womack Building, Campus Box # 7172 UNC-CH, Chapel Hill, NC, 27599-7170, USA.
Mark A WeaverUNC Gillings School of Global Public Health, Chapel Hill, USA.
Maihan B VuCenter for Health Promotion and Disease Prevention, UNC Chapel Hill, Chapel Hill, USA.
April ReeseNorth Carolina Division of Public Health, Chapel Hill, USA.
C Madeline MitchellCecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Tamara BlakeneyCecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Kimberlea GrimmCecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Jennifer ReesCecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Katrina E DonahueCecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
University of North Carolina at Chapel Hill · USNorth Carolina Division of Public Health · USUniversity of North Carolina Health Care · US

Funding

North Carolina Translational & Clinical Sciences Institute (NC TraCS)UL1TR001111 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, CAREY, TIMOTHY S · 2013 to 2017
$43.9M
NCATS NIH HHS UL1 TR001111
6 · The paper itself

Abstract

backgroundFor the nearly 75% of patients living with type 2 diabetes (T2DM) that do not use insulin, decisions regarding self-monitoring of blood glucose (SMBG) can be especially problematic. While in theory SMBG holds great promise for sparking favorable behavior change, it is a resource intensive activity without firmly established patient benefits. This study describes our study protocol to assess the impact of three different SMBG testing approaches on patient-centered outcomes in patients with non-insulin treated T2DM within a community-based, clinic setting. METHODS/

designUsing stakeholder engagement approach, we developed and implemented a pragmatic trial of patient with non-insulin treated T2DM patients from five primary care practices randomized to one of three SMBG regimens: 1) no testing; 2) once daily testing with standard feedback consisting of glucose values being immediately reported to the patient through the glucose meter; and 3) once daily testing with enhanced patient feedback consisting of glucose values being immediately reported to the patient PLUS automated, tailored feedback messaging delivered to the patient through the glucose meter following each testing. Main outcomes assessed at 52 weeks include quality of life and glycemic control. DISCUSSION: This pragmatic trial seeks to better understand the value of SMBG in non-insulin treated patients with T2DM. This paper outlines the protocol used to implement this study in fifteen community-based primary care practices and highlights the impact of stakeholder involvement from the earliest stages of project conception and implementation. Plans for stakeholder involvement for result dissemination are also discussed.

trial registrationClinicalTrials.gov NCT02033499 , January 9, 2014.

Indexed as

Blood GlucoseBlood Glucose Self-MonitoringClinical ProtocolsDiabetes Mellitus, Type 2FemaleGlycated HemoglobinHumansHypoglycemiaMaleMiddle AgedPatient Outcome AssessmentQuality of LifeResearch DesignBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanGlycemic controlPragmatic clinical trialSelf-monitoring of blood glucoseSMBGType 2 diabetes

Identifiers

PMID28545493
PMCPMC5445357
OpenAlexW2619638784

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.